Business Focus
Clinical Focus
Spotlight
100 Years
CME/CE
Job Board
Adding saxagliptin to metformin results in better glycemic control vs. uptitrating metformin dose
Adding saxagliptin to metformin instead of increasing the dose of metformin results in significant improvement in levels of hemoglobin 1c (HbA1c), fasting plasma glucose, and postprandial glucose in patients with type 2 diabetes with inadequate glycemic control despite being on a stable dose of metformin, according to the results of a randomized open-label study.
Related Videos
Related Content
